Search Within

Stephen Stacy Roberts

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (38)
  2. Journal Article (36)
Groups
  1. GSK Faculty (74)
  2. Neuroblastoma Service (74)
  3. Pediatrics, Department of (74)
  4. Tow Center for Developmental Oncology (TCDO) (71)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (62)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (39)

More Groups

People
  1. Nai-Kong Cheung (61)
  2. Shakeel Modak (61)
  3. Brian Kushner (58)
  4. Ellen Basu (56)
  5. Kim Kramer (30)
  6. Suzanne Wolden (16)

More People

Years
  1. 2025 (1)
  2. 2023 (9)
  3. 2022 (4)
  4. 2021 (6)
  5. 2020 (6)
  6. 2019 (13)

More Years

Publications
  1. Pediatric Blood and Cancer (24)
  2. Journal of Clinical Oncology (9)
  3. Cancer (4)
  4. Cancer Research (4)
  5. International Journal of Cancer (4)
  6. Neuro-Oncology (4)

More Publications

Publishers
  1. Wiley Periodicals, Inc (25)
  2. American Society of Clinical Oncology (10)
  3. American Association for Cancer Research (6)
  4. John Wiley & Sons (4)
  5. Oxford University Press (4)
  6. Wiley Blackwell (4)

More Publishers

Results (74)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Survival impact of anti-GD2 antibody response - A phase II ganglioside vaccine trial in relapsed neuroblastoma
    Meeting Abstract

    Cheung, I. Y.; Cheung, N. K. V.; Modak, S.; Mauguen, A.; Basu, E.; Roberts, S. S.; Ragupathi, G.; Kushner, B. H.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Favorable toxicity profile of bivalent GD2/GD3 neuroblastoma vaccine
    Meeting Abstract

    Modak, S.; Cheung, N. K.; Basu, E.; Roberts, S.; Kushner, B.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Prospective agnostic germline testing in pediatric cancer patients
    Meeting Abstract

    Fiala, E.; Kennedy, J.; Kemel, Y.; Mauguen, A.; Mandelker, D.; Zehir, A.; Birsoy, O.; Bouvier, N.; Maio, A.; Latham, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma
    Journal Article

    Luo, L. Y.; Kramer, K.; Cheung, N. K. V.; Kushner, B. H.; Modak, S.; Basu, E. M.; Roberts, S. S.; Wolden, S. L.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Extracellular vesicle and particle biomarkers define multiple human cancers
    Journal Article

    Hoshino, A.; Kim, H. S.; Bojmar, L.; Gyan, K. E.; Cioffi, M.; Hernandez, J.; Zambirinis, C. P.; Rodrigues, G.; Molina, H.; Heissel, S.; more...
    Cell (2020)

    Fulltext@MSK | Save
  • ATRX in-frame fusion neuroblastoma is sensitive to EZH2 inhibition via modulation of neuronal gene signatures
    Journal Article

    Qadeer, Z. A.; Valle-Garcia, D.; Hasson, D.; Sun, Z.; Cook, A.; Nguyen, C.; Soriano, A.; Ma, A.; Griffiths, L. M.; Zeineldin, M.; more...
    Cancer Cell (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for high-risk neuroblastoma: Efficacy against histologically-evident primary refractory metastases in bone marrow
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) PLUS stepped-up dosing of granulocyte-macrophage colony-stimulating factor for neuroblastoma: Outpatient treament low immunogenicity, and major responses in a phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save